Analysis and impact of a multidisciplinary lymphoma virtual tumor board

Habermann, Thomas M.; Khurana, Arushi; Lentz, Ruth; Schmitz, John J.; Bormann, Alexander G. von; Young, Jason R.; Hunt, Christopher H.; Christofferson, Sara N.; Nowakowski, Grzegorz S.; McCullough, Kristen; Horna, Pedro; Wood, Adam; Macon, William R.; Kurtin, Paul J.; Lester, Scott C.; Stafford, Scott L.; Chamarthy, Ushrasree; Khan, Faraz; Ansell, Stephen M.; King, Rebecca

doi:10.1080/10428194.2020.1817432

Cited by 18 publications

(17 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Others have investigated the impact of multidisciplinary tumor boards on the quality of diagnosis and treatment and found that between 4% and 45% of presented cases saw changes in the diagnosis or staging and between 4.5% and 52% recommendations saw changes in the management plan, as summarized by Habermann et al. [ 10 ]. The systematic analysis of the feasibility of the recommendations made at the abovementioned LATB showed that only 64% of all recommendations and 60% of diagnostics-related recommendations could be implemented [ 9 ], while on-site tumor boards were reported to result in 75–90% of feasible recommendations [ 11 , 12 ].…”

Section: Discussionmentioning

confidence: 99%

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe

Thallinger

Berzinec

Bicakcic

et al. 2022

Wien Klin Wochenschr

View full text Add to dashboard Cite

Summary Purpose To establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). Methods We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. Results A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). Conclusion When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‑2 (severe acute respiratory syndrome coronavirus type 2) pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe

Thallinger

Berzinec

Bicakcic

et al. 2022

Wien Klin Wochenschr

View full text Add to dashboard Cite

show abstract

“…Secure email is an established communication tool for provider collaboration; however, these messages frequently occur outside health records and are not captured, causing data fragmentation. Virtual tumor boards existed before 2020 12 , 71 ; however, during the pandemic, they were implemented at health systems across the country. 72 Virtual tumor boards improve recommendations, increase collaboration and educational opportunities, and are viewed favorably by participants.…”

Section: Virtual Care In Oncologymentioning

confidence: 99%

Lessons for Oncology From the COVID-19 Pandemic

Roberts

Lennes

2022

Cancer J

View full text Add to dashboard Cite

After several decades of slow expansion, the use of virtual care in oncology rapidly expanded during the COVID-19 pandemic. Data from cancer centers across the country show that most patients and providers were satisfied with components of virtual care, and virtual care may be able to improve access to care. However, the rapid implementation of programs during the pandemic worsened disparities in access to virtual care. Health systems must develop strategies to monitor quality, support patients and providers, promote health equity, and overcome regulatory challenges to successfully deliver care in hybrid systems that combine in-person and virtual care.

show abstract

Section: Introductionmentioning

confidence: 99%

“…As a result, several groups established virtual MDTs to address this critical need in rural community settings and showed virtual meetings to be feasible and effective in improving care. [5][6][7][8][9] Despite studies showing that virtual MDTs were practical, inperson meetings have remained the gold standard at large centers.…”

Section: Introductionmentioning

confidence: 99%

Lessons learned and keys to success: Provider experiences during the implementation of virtual oncology tumor boards in the era of COVID‐19

Perlmutter

Said

Hossain

et al. 2022

Journal of Surgical Oncology

View full text Add to dashboard Cite

Background and Objectives: The COVID-19 pandemic required rapid adaptation of multidisciplinary tumor board conferences to a virtual setting; however, there are little data describing the benefits and challenges of using such a platform.Methods: An anonymous quality improvement survey was sent to participants of tumor board meetings at a large academic institution. Participants answered questions pertaining to the relative strengths and weaknesses of in-person and virtual settings.Results: A total of 335 responses (23.3% response rate) were recorded, and 253 met inclusion criteria. Respondents represented 25 different tumor board meetings, with colorectal, breast, and liver (18.6%, 17.0%, and 13.0%, respectively) being the most commonly attended. Virtual tumor boards were equivalent to in-person across 9 of 10 domains queried, while a virtual format was preferred for participation in off-site tumor boards. The lack of networking opportunities was ranked by physicians to be a significant challenge of the virtual format. Consistent leadership and organization, engaged participation of all attendees, and upgrading technology infrastructure were considered critical for success of virtual meetings. Conclusions:The implementation of virtual tumor board meetings has been associated with numerous challenges. However, improving several key aspects can improve participant satisfaction and ensure excellent patient care.

show abstract

Analysis and impact of a multidisciplinary lymphoma virtual tumor board

Cited by 18 publications

References 53 publications

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe

Lessons for Oncology From the COVID-19 Pandemic

Lessons learned and keys to success: Provider experiences during the implementation of virtual oncology tumor boards in the era of COVID‐19

Contact Info

Product

Resources

About